Chair & CEO at Eli Lilly and Company
One successful drug can represent several billion dollars when you include all the failed programs. Estimates around $3.5–$4B feel directionally right. Costs are not just science; they include global trials, manufacturing scale-up, safety monitoring, and post-approval commitments. Pricing discussions need that whole picture.
This answer is part of a full interview with Dave Ricks, Chair & CEO at Eli Lilly and Company.
Found this insight valuable? Share it with your network to help others learn from Dave Ricks's experience.
Use this answer in your research, article, or academic work
